A new drug lowers levels of a protein related to ‘bad’ cholesterol

The next clinical trial will test if the treatment reduces the risk of heart attack and stroke

doctor talking to a patient

Testing for a person’s level of lipoprotein(a), which carries fat and cholesterol, could become widespread if a new drug that can drastically reduce the protein is found to lower the risk of heart attack and stroke.

FatCamera/getty images plus

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content